156 related articles for article (PubMed ID: 34550868)
1. Bio-informatics and in Vitro Experiments Reveal the Mechanism of Schisandrin A Against MDA-MB-231 cells.
Chen L; Ren LQ; Liu Z; Liu X; Tu H; Huang XY
Bioengineered; 2021 Dec; 12(1):7678-7693. PubMed ID: 34550868
[TBL] [Abstract][Full Text] [Related]
2. Schizandrin A induces non-small cell lung cancer apoptosis by suppressing the epidermal growth factor receptor activation.
Zhu L; Wang Y; Huang X; Liu X; Ye B; He Y; Yu H; Lv W; Wang L; Hu J
Cancer Med; 2024 Jan; 13(2):e6942. PubMed ID: 38376003
[TBL] [Abstract][Full Text] [Related]
3. Schizandrin A inhibits cellular phenotypes of breast cancer cells by repressing miR-155.
Yan H; Guo M
IUBMB Life; 2020 Aug; 72(8):1640-1648. PubMed ID: 32623835
[TBL] [Abstract][Full Text] [Related]
4. A Network Pharmacology and Molecular Docking Strategy to Explore Potential Targets and Mechanisms Underlying the Effect of Curcumin on Osteonecrosis of the Femoral Head in Systemic Lupus Erythematosus.
Kang P; Wu Z; Zhong Y; Wang Z; Zhou C; Huo S; Guo H; Li S; Xu K; Liu L; Chen S; Tang H; Wang H
Biomed Res Int; 2021; 2021():5538643. PubMed ID: 34557547
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of Tetrandrine Against Endometrial Cancer Based on Network Pharmacology.
Shang W; Zhang J; Song H; Zhu S; Zhang A; Hua Y; Han S; Fu Y
Drug Des Devel Ther; 2021; 15():2907-2919. PubMed ID: 34262258
[TBL] [Abstract][Full Text] [Related]
6. Integrating Bioinformatics and Network Pharmacology to Explore the Therapeutic Target and Molecular Mechanisms of Schisandrin on Hypertrophic Cardiomyopathy.
Shen C; Shen P; Wang X; Wang X; Shao W; Geng K; Xie H
Curr Comput Aided Drug Des; 2023; 19(3):192-201. PubMed ID: 36424782
[TBL] [Abstract][Full Text] [Related]
7. Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway.
Xu X; Rajamanicham V; Xu S; Liu Z; Yan T; Liang G; Guo G; Zhou H; Wang Y
Biomed Pharmacother; 2019 Jul; 115():108922. PubMed ID: 31048190
[TBL] [Abstract][Full Text] [Related]
8. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
9. Schizandrin A exerts anti-tumor effects on A375 cells by down-regulating H19.
Bi Y; Fu Y; Wang S; Chen X; Cai X
Braz J Med Biol Res; 2019; 52(10):e8385. PubMed ID: 31618367
[TBL] [Abstract][Full Text] [Related]
10. MEG3 is restored by schisandrin A and represses tumor growth in choriocarcinoma cells.
Ji L; Ma L
J Biochem Mol Toxicol; 2020 Apr; 34(4):e22455. PubMed ID: 32057180
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential anti-tumor targets and mechanisms of HuaChanSu injection using network pharmacology and cytological experiments in Breast cancer.
Yang Z; Wang Y; Huang S; Geng Y; Yang Z; Yang Z
PLoS One; 2024; 19(5):e0303650. PubMed ID: 38753638
[TBL] [Abstract][Full Text] [Related]
12. Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification.
Deng Z; Chen G; Shi Y; Lin Y; Ou J; Zhu H; Wu J; Li G; Lv L
Front Pharmacol; 2022; 13():920514. PubMed ID: 36003508
[No Abstract] [Full Text] [Related]
13. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic insights into the renoprotective role of curcumin in cisplatin-induced acute kidney injury: network pharmacology analysis and experimental validation.
Hui Z; Dong QQ; Shu HP; Tu YC; Liao QQ; Yao LJ
Bioengineered; 2021 Dec; 12(2):11041-11056. PubMed ID: 34802380
[TBL] [Abstract][Full Text] [Related]
15. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of astragaloside Ⅳ alleviating PC12 cell injury by activating PI3K/AKT signaling pathway: based on network pharmacology and in vitro experiments].
Zhang TQ; Li CC; Zhang TF; Wang MY; Cui SN; Huo Q
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6465-6473. PubMed ID: 34994139
[TBL] [Abstract][Full Text] [Related]
17. Unravelling the anti-inflammatory mechanism of Allium cepa: an integration of network pharmacology and molecular docking approaches.
Omoboyede V; Onile OS; Oyeyemi BF; Aruleba RT; Fadahunsi AI; Oke GA; Onile TA; Ibrahim O; Adekiya TA
Mol Divers; 2024 Apr; 28(2):727-747. PubMed ID: 36867320
[TBL] [Abstract][Full Text] [Related]
18. A network pharmacology approach to explore the potential targets underlying the effect of sinomenine on rheumatoid arthritis.
Guo X; Ji J; Feng Z; Hou X; Luo Y; Mei Z
Int Immunopharmacol; 2020 Mar; 80():106201. PubMed ID: 31972421
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract][Full Text] [Related]
20. Schizandrin A can inhibit non‑small cell lung cancer cell proliferation by inducing cell cycle arrest, apoptosis and autophagy.
Zhu L; Wang Y; Lv W; Wu X; Sheng H; He C; Hu J
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34643254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
